Shares of diversified life sciences company Azenta (NASDAQ:AZTA) were down by a noteworthy 15.5% as of 10:07 a.m. ET Thursday morning. The healthcare company's shares were pulling back after its preliminary 2022 third-quarter results missed Wall Street's consensus revenue figure.

Specifically, Azenta's initial third-quarter revenue forecast of $133 million is $11 million less than analysts' average figure for the three-month period. The biopharma's shares are also under pressure from the broad-based downward trend across the healthcare sector this morning.

Image source: Getty Images.

Continue reading

Source Fool.com